Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2020, after the close of the financial markets on Monday, August 3, 2020.

Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Monday, August 3 at 4:30 PM ET to review results.

Conference Call DetailsDate: Monday, August 3, 2020 – 4:30 PM ETDial-in: 877-407-6184International dial-in: 201-389-0877Conference Call Name: Xtant Medical Q2 2020 Financial ResultsWebcast Registration: Click Here

Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

Investor Relations Contact

David CareyLazar FINN PartnersPh: 212-867-1768Email: david.carey@finnpartners.com

Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more Xtant Medical Charts.
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more Xtant Medical Charts.